USC.edu
Are You a Patient?

Donald Barkauskas, PhD

Professor of Clinical Population and Public Health Sciences

Image of Donald Barkauskas, PhD
Is this your profile? Click to edit
Phone +1 323 442 1212
Email [email protected]
CTSI Profile

Publications

  • SMARCAL1 is a new osteosarcoma predisposition gene. J Natl Cancer Inst. 2026 Jun 01; 118(6):1120-1125.. View in PubMed
  • Malignant peripheral nerve sheath tumors: a report from Children’s Oncology Group study ARST0332. J Natl Cancer Inst. 2026 May 01; 118(5):829-838.. View in PubMed
  • High dose interleukin-2 in combination with anti-programmed cell death protein 1 to overcome immune checkpoint inhibitor resistance in metastatic melanoma and renal cell carcinoma. Melanoma Res. 2026 Apr 30.. View in PubMed
  • NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition. Mol Cancer Ther. 2026 Apr 21.. View in PubMed
  • Leveraging Large Language Models to Extract Prognostic Pathology Features in Ewing Sarcoma. bioRxiv. 2026 Mar 19.. View in PubMed
  • Alveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children’s Oncology Group Study ARST0332. Pediatr Blood Cancer. 2026 May; 73(5):e70228.. View in PubMed
  • NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition. bioRxiv. 2025 Jul 31.. View in PubMed
  • The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children’s Oncology Group. HGG Adv. 2025 Jul 10; 6(3):100466.. View in PubMed
  • ICOS and ICOS ligand: expression patterns and outcomes in oncology patients. Ther Adv Med Oncol. 2025; 17:17588359251330514.. View in PubMed
  • Larotrectinib for Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion-Positive Solid Tumors (Children’s Oncology Group ADVL1823). J Clin Oncol. 2025 04; 43(10):1188-1197.. View in PubMed

Similar People